Participant cancer and treatment information (n = 25). Chemotherapy and immunotherapy treatment counts are not mutually exclusive
| Characteristic of cancer diagnosis and treatment | n (%) | |
|---|---|---|
| Cancer stage | Stage 1 | 1 (4.0%) |
| Stage 2 | 3 (12.0%) | |
| Stage 3 | 5 (20.0%) | |
| Stage 4 | 11 (44.0%) | |
| Unknown | 5 (20.0%) | |
| Cancer type | Lung | 7 (28.0%) |
| Colon | 3 (12.0%) | |
| Breast | 3 (12.0%) | |
| Adenoid | 2 (8.0%) | |
| Prostate | 2 (8.0%) | |
| Rectal | 2 (8.0%) | |
| Thyroid | 1 (4.0%) | |
| Germ cell | 1 (4.0%) | |
| Brain | 1 (4.0%) | |
| Ewing’s sarcoma | 1 (4.0%) | |
| Kidney | 1 (4.0%) | |
| Skin | 1 (4.0%) | |
| Treatment | Observation | 11 (44.0%) |
| Chemotherapy | 12 (48.0%) | |
| Immunotherapy | 4 (16.0%) | |